CATX:NYSEAMERICAN
Perspective Therapeutics Inc
$2.50
arrow_downward
-0.79%(-0.020) 1D
$2.54
arrow_upward
+1.60% (+0.040)bedtimeAfter hours
Closed: Sep 28, 4:00:00 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CATX...
Open
$2.50
High
$2.58
Low
$2.46
Mkt. cap
285.38M
Avg. vol.
1.79M
Volume
1.50M
52-wk high
$6.16
52-wk low
$1.96
EPS
-$1.33
Beta
1.80
Shares outstanding
114.15M
No. of employees
163
Open
$2.50
High
$2.58
Low
$2.46
Mkt. cap
285.38M
Avg. vol.
1.79M
Volume
1.50M
52-wk high
$6.16
52-wk low
$1.96
EPS
-$1.33
Beta
1.80
Shares outstanding
114.15M
No. of employees
163
News stories
From web sources and news partners
https://www.dars.gov.et/
·
1 week ago
Perspective Therapeutics (CATX) Climbs 3.13% to $2.97, Nearing Resistance at $3.12 - Spring Pattern
https://www.dars.gov.et/
·
2 months ago
Perspective Therapeutics Dips 0.67% as Stock Hovers Near Support Zone - Zero Gamma Level
Profile
Isoray Inc. is a national isotope-based medical company and the sole producer of Cesium brachytherapy sources, which are expanding brachytherapy treatments for difficult to treat cancers. Isoray is a registered manufacturer with the FDA and holds multiple 510 clearances for brachytherapy devices. The brachytherapy isotopes are sold under the brandname Blu.
The company went public in 2005. Isoray’s corporate headquarters is located at 350 Hills Street, Suite 106, Richland WA 99354. Wikipedia
About Perspective Therapeutics Inc
CEO-
Employees163
Founded2004
HeadquartersSeattle, Washington, United States
SectorBiotechnology
Websiteperspectivetherapeutics.com